Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. - Wikidata - awgldk - TriplyDB

Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.

Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.

http://www.wikidata.org/entity/Q37345411

about

Untreated type 2 diabetes and its complications are associated with subcortical infarctions Proton MRS in mild cognitive impairment.Magnetic resonance spectroscopy in common dementias Advances in high-field magnetic resonance spectroscopy in Alzheimer's disease EFFECT OF TYPE 2 DIABETES MELLITUS ON BRAIN METABOLITES BY USING PROTON MAGNETIC RESONANCE SPECTROSCOPY-A SYSTEMATIC REVIEW.Aortic hemodynamics and white matter hyperintensities in normotensive postmenopausal women.18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques.Antemortem MRI findings associated with microinfarcts at autopsy.Effects of age on the glucose metabolic changes in mild cognitive impairment.mNos2 deletion and human NOS2 replacement in Alzheimer disease models Emerging biomarkers in cognition.Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.Should mild cognitive impairment be subtyped?Differential effects of ischemic vascular disease and Alzheimer's disease on brain atrophy and cognition.Atrial fibrillation, cognitive impairment, and neuroimaging 1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment Similar verbal fluency patterns in amnestic mild cognitive impairment and Alzheimer's disease.MR spectroscopy for assessment of memantine treatment in mild to moderate Alzheimer dementia MRI and MRS predictors of mild cognitive impairment in a population-based sample.Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis.Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment.Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors.Gray matter volume and dual-task gait performance in mild cognitive impairment Association of Kidney Function Biomarkers with Brain MRI Findings: The BRINK Study.Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.Brain Biomarkers in Familial Alzheimer's Disease Mouse Models.Sports concussions and aging: a neuroimaging investigation.Changes in mild cognitive impairment and its subtypes as seen on diffusion tensor imaging.Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly.In vivo 18F-AV-1451 tau-PET signal in MAPT mutation carriers varies by expected tau isoforms.White-matter integrity on DTI and the pathologic staging of Alzheimer's disease.

P2860

Q24626249-697C46E2-78D6-44B4-B623-83A4C2210072 Q30606675-60A83557-9002-444F-8708-B212BD264D3B Q30660402-F1CC43EB-E16D-4C1E-8380-EEDC52507562 Q30770751-B31E2249-DBDD-4A28-9BDA-4BB3495B0869 Q30883281-19464021-8315-40C8-B813-641918A3CB22 Q33627819-AD571887-FB6F-47FA-BE62-EDE2C8EB530E Q33740879-DA0E966D-6534-4881-B5E2-EAC286392D8C Q33808785-BE393949-9340-4F65-A807-A1E8E1849E8B Q33875000-E7B094FB-1100-410A-8885-AE7F6950583B Q33927219-2433BDD4-3325-4BE9-B0DA-C4425670CF21 Q33931288-30C0438C-3D88-4142-80FE-E94BC21133B7 Q34041402-B6CCFB24-856C-410E-8703-019E73417BEE Q35008258-97E0B690-40FE-4D96-AD7C-5DDF8D34C058 Q35119419-C82367F5-81F8-4CEA-9E52-014F0AD1A2C1 Q36002365-9E14D17A-7DD3-4451-AAE8-A31F6FE10241 Q36593197-E7A0C497-DCDB-4A54-B326-631AFF65D490 Q36827384-8E2C0670-EC8B-43F3-B5A0-1C2031B491C3 Q36939456-AD972C5A-8D1A-4922-950A-0DD0364687F1 Q37012743-7476F188-B1EB-4749-B93E-30F40448ECFE Q37150803-2C13C59D-651E-4F7C-8DF4-FD5D894FB608 Q37163305-2821C853-F092-44A6-88B9-53BAAB7A9F85 Q37448226-099FA327-87CE-4D26-B82A-B6D5DC5EED29 Q37468579-40FC84F4-C550-47D0-BDBA-F4D08ECC5BC9 Q37544204-3E316BEC-3009-4D77-ABEB-07926625708F Q37607093-DB97554F-9190-414C-A235-0407E43076A4 Q40526523-3C440D08-2321-4386-8815-F7EA60E99D6B Q48063748-B4C0E79E-EBD1-4F35-95D4-A591A313F541 Q48108053-4B942FC3-5B17-4925-B23F-6D419E888957 Q48515080-4A2E1B76-40BE-48DB-8D56-F671AEDF1C6D Q48595305-98BC7EAA-620E-439B-9D73-3630C4B83DD0 Q49990629-BAB588FC-5974-4EEA-9FF5-F2F5BC8B9E0A Q50026038-9A34C8B9-0620-44A7-8EF7-9536EC6F82FD Q50618207-009DFAFB-04BB-4111-BEB3-E3854CF9A723

P2860

Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.

http://www.wikidata.org/entity/Q37345411

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hippocampal volumes, proton ma ...... cognitive impairment subtypes.

@en

Hippocampal volumes, proton ma ...... cognitive impairment subtypes.

@nl

type

label

Hippocampal volumes, proton ma ...... cognitive impairment subtypes.

@en

Hippocampal volumes, proton ma ...... cognitive impairment subtypes.

@nl

prefLabel

Hippocampal volumes, proton ma ...... cognitive impairment subtypes.

@en

Hippocampal volumes, proton ma ...... cognitive impairment subtypes.

@nl

P1433

Q37345411-99E99FCF-7FA0-4ACE-A2AF-DDFDE413433E

P1476

Q37345411-0C23322E-0E46-4404-B5B0-381BF0A7C75A

P2093

Q37345411-06D655C0-45E0-479B-835A-BB2D5A75770C

Q37345411-164AE0FE-357E-4D2B-85D4-EF6C22ACBC1E

Q37345411-3770E7B8-D6A2-420E-A3FE-6B813749C184

Q37345411-46605AA7-9640-4A44-B20E-61ED8E5F1BED

Q37345411-98839B1E-5AF7-4464-945D-2A38D0750125

Q37345411-D12BE288-2A5A-4436-8183-7172DC0154F1

Q37345411-EC261B2D-102E-47E2-9695-C3117A4A199A

P2860

Q37345411-007C0569-F2FC-4111-B8AA-9C176EF140CC

Q37345411-00851738-E9E0-4595-859A-D49BD1DDA821

Q37345411-0373D519-9629-4992-A46E-3F5D5A05EE16

Q37345411-0E998DC7-5E0D-46E4-8E13-1B61FDE2F967

Q37345411-1396C9E6-02DA-4602-A996-32E447930F65

Q37345411-20F205B3-E206-49DC-BB71-EDB22782F61F

Q37345411-26F3607B-C019-48FC-A5A3-38B9D8B610E0

Q37345411-31B2D4ED-EB77-4ABD-B97A-9145CA8F4498

Q37345411-32E57610-1984-40C6-B885-25F233E866E9

Q37345411-48C1B0A8-733E-4A5C-8826-1402FFD7AB5D

P304

Q37345411-413EF252-F628-4822-882C-E407DEDEBF11

P31

Q37345411-B29F34BF-4A66-4A38-AD74-EBED9B8C675B

P356

Q37345411-AC98D3C5-3E20-4F8B-AB4E-FBD4DC5CEF36

P433

Q37345411-D9CC8A12-1E18-427A-B0AF-7DE5C820BCED

P478

Q37345411-C829799B-83EC-4BDE-BC23-CB852B124C74

P50

Q37345411-078EEB8C-BEAE-49E0-A871-BB06D2D0972B

Q37345411-2FA413EF-DFFC-44A5-9FE9-A4BB15DF24AF

Q37345411-339746AA-C079-4996-AB1D-945245601C7B

Q37345411-4BE2D667-71CA-4DA0-8BB1-687E71ED3D94

Q37345411-57645CA5-A767-4842-B234-F3CCF69E45E6

P577

Q37345411-2205494D-C20D-4CF3-B391-1F7AD0BE7DC6

P5875

Q37345411-2C57E11D-67B6-4EA7-9476-03E2BD53EB1C

P698

Q37345411-DFE1AFEE-39CB-43C5-ACF8-0E5061B4AF20

P932

Q37345411-11EA1144-FDA1-4724-A128-804E82073AD5

P356

ARCHNEUR.65.12.1621

P1433

P1476

Hippocampal volumes, proton ma ...... cognitive impairment subtypes.

@en

P2093

Bradley F Boeve

http://www.w3.org/2001/XMLSchema#string

Glenn E Smith

http://www.w3.org/2001/XMLSchema#string

Jennifer L Whitwell

http://www.w3.org/2001/XMLSchema#string

Maria M Shiung

http://www.w3.org/2001/XMLSchema#string

Robert J Ivnik

http://www.w3.org/2001/XMLSchema#string

Scott A Przybelski

http://www.w3.org/2001/XMLSchema#string

Stephen D Weigand

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropathologic features of amnestic mild cognitive impairment

What's wrong with Bonferroni adjustments.

Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.

Mild cognitive impairment represents early-stage Alzheimer disease.

Natural history of mild cognitive impairment in older persons.

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.

Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia.

Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD

P304

1621-1628

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUR.65.12.1621

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Ronald C. Petersen

David S Knopman

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23640133

http://www.w3.org/2001/XMLSchema#string

P698

19064749

http://www.w3.org/2001/XMLSchema#string

P932

2743393

http://www.w3.org/2001/XMLSchema#string